PEAK6 Investments’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,300
Closed -$41.1K 4439
2023
Q3
$41.1K Sell
7,300
-7,700
-51% -$51.3K ﹤0.01% 3663
2023
Q2
$82.8K Hold
15,000
﹤0.01% 3302
2023
Q1
$93.8K Buy
+15,000
New +$83.6K ﹤0.01% 3538
2022
Q4
Sell
-37,300
Closed -$174K 4695
2022
Q3
$174K Sell
37,300
-159,700
-81% -$1.01M ﹤0.01% 3771
2022
Q2
$1.16M Sell
197,000
-82,900
-30% -$923K ﹤0.01% 2921
2022
Q1
$5.41M Buy
279,900
+26,800
+11% +$615K 0.01% 1050
2021
Q4
$8.27M Sell
253,100
-337,300
-57% -$13.6M 0.02% 819
2021
Q3
$24.2M Buy
590,400
+93,400
+19% +$3.39M 0.05% 308
2021
Q2
$17.9M Buy
497,000
+264,700
+114% +$9.77M 0.04% 417
2021
Q1
$9.06M Buy
+232,300
New +$10.4M 0.02% 691

Other funds holding GDRX

PEAK6 Investments's GDRX Position: Q4 2023 in Review

PEAK6 Investments sold out of GoodRx Holdings (GDRX) in Q4 2023, closing a stake of 51,643 shares — an estimated $291K sold.

PEAK6 Investments first reported a position in GDRX in Q1 2021 and held it in 11 quarters. The position peaked at $3.43M in Q1 2021. 143 funds tracked by Wall St. Rank hold GDRX as of Q4 2023.

  • PEAK6 Investments reported no remaining GoodRx Holdings position as of Q4 2023 after selling out during the quarter.
  • PEAK6 Investments sold 51,643 GoodRx Holdings shares in Q4 2023, an estimated $291K.
  • PEAK6 Investments first reported a position in GoodRx Holdings in Q1 2021 and held it in 11 quarters.
  • PEAK6 Investments's GoodRx Holdings position peaked at $3.43M in Q1 2021.
  • 143 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2023.

Based on PEAK6 Investments's 13F filing for Q4 2023, filed 13 Feb 2024.